160 related articles for article (PubMed ID: 16989587)
1. Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis.
Bouros D; Antoniou KM; Tzouvelekis A; Siafakas NM
Expert Opin Biol Ther; 2006 Oct; 6(10):1051-60. PubMed ID: 16989587
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma1b therapy in idiopathic pulmonary fibrosis: a metaanalysis.
Bajwa EK; Ayas NT; Schulzer M; Mak E; Ryu JH; Malhotra A
Chest; 2005 Jul; 128(1):203-6. PubMed ID: 16002936
[TBL] [Abstract][Full Text] [Related]
3. Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?
Prasse A; Müller KM; Kurz C; Hamm H; Virchow JC
Eur Respir J; 2003 Dec; 22(6):906-11. PubMed ID: 14680077
[TBL] [Abstract][Full Text] [Related]
4. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.
King TE; Safrin S; Starko KM; Brown KK; Noble PW; Raghu G; Schwartz DA
Chest; 2005 Jan; 127(1):171-7. PubMed ID: 15653980
[TBL] [Abstract][Full Text] [Related]
5. [Idiopathic pulmonary fibrosis (IPF)].
Matsumoto A; Azuma A
Nihon Rinsho; 2006 Jul; 64(7):1354-60. PubMed ID: 16838656
[TBL] [Abstract][Full Text] [Related]
6. Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).
Antoniou KM; Alexandrakis MG; Sfiridaki K; Tsiligianni I; Perisinakis K; Tzortzaki EG; Siafakas NM; Bouros DE
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):105-10. PubMed ID: 15281431
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma 1b: impact of new indications (idiopathic pulmonary fibrosis).
Aggarwal AN; Behera D
Expert Opin Pharmacother; 2000 Dec; 1(7):1423-7. PubMed ID: 11249475
[TBL] [Abstract][Full Text] [Related]
8. Investigation of IL-18 and IL-12 in induced sputum of patients with IPF before and after treatment with interferon gamma-1b.
Antoniou KM; Tzortzaki EG; Alexandrakis MG; Zervou M; Tzanakis N; Sfiridaki K; Bouros DE; Siafakas NM
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):204-9. PubMed ID: 16315783
[TBL] [Abstract][Full Text] [Related]
9. Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis.
Strieter RM; Starko KM; Enelow RI; Noth I; Valentine VG;
Am J Respir Crit Care Med; 2004 Jul; 170(2):133-40. PubMed ID: 15044205
[TBL] [Abstract][Full Text] [Related]
10. Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis.
Tzortzaki EG; Antoniou KM; Zervou MI; Lambiri I; Koutsopoulos A; Tzanakis N; Plataki M; Maltezakis G; Bouros D; Siafakas NM
Respir Med; 2007 Aug; 101(8):1821-9. PubMed ID: 17391951
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.
Selman M; Thannickal VJ; Pardo A; Zisman DA; Martinez FJ; Lynch JP
Drugs; 2004; 64(4):405-30. PubMed ID: 14969575
[TBL] [Abstract][Full Text] [Related]
12. Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis.
Pockros PJ; Jeffers L; Afdhal N; Goodman ZD; Nelson D; Gish RG; Reddy KR; Reindollar R; Rodriguez-Torres M; Sullivan S; Blatt LM; Faris-Young S
Hepatology; 2007 Mar; 45(3):569-78. PubMed ID: 17326152
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary fibrosis--a therapeutic dilemma?].
Günther A; Markart P; Eickelberg O; Seeger W
Med Klin (Munich); 2006 Apr; 101(4):308-12. PubMed ID: 16607487
[TBL] [Abstract][Full Text] [Related]
14. Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis.
Shoda H; Yokoyama A; Nishino R; Nakashima T; Ishikawa N; Haruta Y; Hattori N; Naka T; Kohno N
Biochem Biophys Res Commun; 2007 Feb; 353(4):1004-10. PubMed ID: 17198680
[TBL] [Abstract][Full Text] [Related]
15. Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Walter N; Collard HR; King TE
Proc Am Thorac Soc; 2006 Jun; 3(4):330-8. PubMed ID: 16738197
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
Wang T; Blatt LM; Seiwert SD
J Interferon Cytokine Res; 2006 Jul; 26(7):473-83. PubMed ID: 16800786
[TBL] [Abstract][Full Text] [Related]
17. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.
Lynch DA; Godwin JD; Safrin S; Starko KM; Hormel P; Brown KK; Raghu G; King TE; Bradford WZ; Schwartz DA; Richard Webb W;
Am J Respir Crit Care Med; 2005 Aug; 172(4):488-93. PubMed ID: 15894598
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of pulmonary fibrosis].
Cottin V
Presse Med; 2002 Oct; 31(34):1613-23. PubMed ID: 12426980
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory agents for idiopathic pulmonary fibrosis.
Davies HR; Richeldi L; Walters EH
Cochrane Database Syst Rev; 2003; (3):CD003134. PubMed ID: 12917947
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.
Antoniou KM; Nicholson AG; Dimadi M; Malagari K; Latsi P; Rapti A; Tzanakis N; Trigidou R; Polychronopoulos V; Bouros D
Eur Respir J; 2006 Sep; 28(3):496-504. PubMed ID: 16611657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
